Basel, 21 April 2020
Reminder: Invitation to Roche’s live audio webcast on new AAN 2020 data
We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Tuesday, 28 April 2020 , highlighting data from the Roche neuroscience portfolio that were accepted to be part of the American Academy Of Neurology 72nd Annual Meeting 2020 and will be available virtually.
Karl Mahler, Head of Investor Relations and Roche Group Planning
- Risdiplam: FIREFISH part 2 efficacy and safety in infants with type 1 SMA
Prof. Laurent Servais, MDUK Oxford Neuromuscular Center, Department of Paediatrics, University of Oxford, UK
- Risdiplam: Update on clinical development program
- OCREVUS: Long-term data on key markers of disability progression in MS Shorter infusion (ENSEMBLE PLUS) data and regulatory update
Paulo Fontoura, M.D. Ph.D., Global Head Neuroscience and Rare Diseases Clinical Development
Please dial in as outlined below:
17:30 – 18:30 CEST / 16:30 - 17:30 BST
11:30 – 12:30 am EDT / 8:30 - 9:30 am PDT
Audio webcast and conference call will start with a presentation, followed by a Q&A session (live access to the speakers).
Access to Audio webcast
Please access by clicking on ir.roche.com.
Access to Conference Call (pre-registration required)
You will receive phone numbers, passcode and your personal PIN to directly access the conference call by pre-registering here.
Should you have any issues with the registration, please dial the following numbers on the day of the conference call 10-15 minutes prior to conference start:
+41 (0) 58 310 50 00 (Europe & RoW)
+44 (0) 207 107 06 13 (UK)
+1 (1) 631 570 5613 (USA)
Other international numbers are available here
A replay of the webcast will be available via ir.roche.com.